Table 2 |
|||||
|
HO-1 mRNA expression in patients with BD |
|||||
|
PBMCs/PMNs |
Ocular involvement |
HLA-B51 |
|||
|
|
|||||
|
- (n = 17) |
+ (n = 16) |
- (n = 10) |
+ (n = 14) |
||
|
|
|||||
|
HO-1 (AU) |
PBMCs |
7.7 ± 3.1 |
5.7 ± 4.1 |
8.1 ± 3.9 |
5.6 ± 3.7 |
|
PMNs |
32.9 ± 46.1 |
31.6 ± 34.1 |
31.6 ± 38.0 |
19.9 ± 18.0 |
|
|
|
|||||
|
Values are expressed as mean ± standard deviation. AU, arbitrary unit; BD, Behçet's disease; HLA, human leukocyte antigen; HO, heme oxygenase; PBMC, peripheral blood mononuclear cells; PMN, peripheral blood multinuclear cells. |
|||||
|
Kirino et al. Arthritis Research & Therapy 2008 10:R16 doi:10.1186/ar2367 |
|||||